Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Neuronal apoptosis is considered to be a crucial therapeutic target against early brain injury (EBI) after subarachnoid hemorrhage (SAH). Emerging evidence indicates that Exendin‐4 (Ex‐4), a glucagon‐like peptide 1 receptor (GLP‐1R) agonist, plays a neuroprotective role in cerebrovascular disease. This study was conducted in order to verify the neuroprotective role of EX‐4 in EBI after SAH in rats. The endovascular perforation model of SAH was performed in Sprague‐Dawley rats (n = 153). Ex‐4 was intraperitoneally injected 1 h after SAH induction in the rats (SAH + Ex‐4). To elucidate the underlying molecular mechanism, small interfering ribonucleic acid (siRNA) for GLP‐1R and a specific inhibitor of PI3K, LY294002, were injected intracerebroventricularly into SAH + Ex‐4 rats before induction of SAH (n = 6 per group). SAH grading evaluation, immunohistochemistry, Western blots, neurobehavioral assessment, and Fluoro‐Jade C (FJC) staining experiments were performed. Expression of GLP‐1R was significantly increased and mainly expressed in neurons at 24 h after SAH induction. Administration of Ex‐4 significantly improved both short‐ and long‐term neurobehavior in SAH + Ex‐4 group compared to SAH + Vehicle group after SAH. Ex‐4 treatment significantly increased the expression of GLP‐1R, PI3K, p‐Akt, Bcl‐xl, and Bcl‐2, while at the same time was found to decrease expression of Bax in the brain. Effects of Ex‐4 were reversed by the intervention of GLP‐1R siRNA and LY294002 in SAH + Ex‐4+GLP‐1R siRNA and SAH + Ex‐4+LY294002 groups, respectively. In conclusion, the neuroprotective effect of Ex‐4 in EBI after SAH was mediated by attenuation of neuronal apoptosis via GLP‐1R/PI3K/Akt signaling pathway, therefore EX‐4 should be further investigated as a potential therapeutic agent in stroke patients. HIGHLIGHTSEx‐4 significantly improved neurological function after SAH.GLP‐1R mainly expressed in neurons after SAH.Ex‐4 did not increased risk of hypoglycemia after SAH in SD rats.Ex‐4 improved spatial learning capacity and reference memory after SAH.The anti‐apoptotic effect of Ex‐4 was mediated via GLP‐1R/PI3K/Akt pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Vorhees, C. V., & Williams, M. T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.116 · Cited by 4,629
Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124
Li, Y., Perry, T., Kindy, M. S., Harvey, B. K., Tweedie, D., Holloway, H. W., Powers, K., Shen, H., Egan, J. M., Sambamurti, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806720106 · Cited by 589 · cited 1×
“There is emerging evidence that besides its anti-diabetic effects, Ex-4 has the potential to carry out a neuroprotective role in central nervous system (CNS) disease (Harkavyi and Whitton, 2010; Li et al., 2009; Perry and Greig, 2005).”
BackgroundGlucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes
Muscogiuri, G., DeFronzo, R. A., Gastaldelli, A., & Holst, J. J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.10.001 · Cited by 171 · cited 1×
“GLP-1R is an emerging potential target in CNS disease (Holscher, 2014; Muscogiuri et al., 2017; Salcedo et al., 2012).”
BackgroundPerry, T., & Greig, N. (2005) · Current Alzheimer Research · doi:10.2174/1567205054367892 · Cited by 127
Neuroprotective Effects of Liraglutide for Stroke Model of Rats
Sato, K., Kameda, M., Yasuhara, T., Agari, T., Baba, T., Wang, F., Shinko, A., Wakamori, T., Toyoshima, A., Takeuchi, H., et al. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121513 · Cited by 120 · cited 4×
“GLP-1R agonists have been reported to be neuroprotective in various diseases of the CNS (Hou et al., 2012; Kuroki et al., 2016; Rachmany et al., 2013; Sato et al., 2013; Teramoto et al., 2011; Zhu et al., 2016).”
BackgroundInfluentialExenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus
Briones, M., & Bajaj, M. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1055 · Cited by 63 · cited 3×
“, 2011) was synthesized to treat adult type 2 diabetes, which was approved by FDA in 2005 (Briones and Bajaj, 2006).”
BackgroundMethodInfluential
Cited by
Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298
Chen, S., Zhao, L., Sherchan, P., Ding, Y., Yu, J., Nowrangi, D., Tang, J., Xia, Y., & Zhang, J. H. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1140-6 · Cited by 122
Self-citationZuo, Y., Huang, L., Enkhjargal, B., Xu, W., Umut, O., Travis, Z. D., Zhang, G., Tang, J., Liu, F., & Zhang, J. H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1432-5 · Cited by 88
Self-citationSun, J.-Y., Zhao, S.-J., Wang, H.-B., Hou, Y.-J., Mi, Q.-J., Yang, M.-F., Yuan, H., Ni, Q.-B., Sun, B.-L., & Zhang, Z.-Y. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00906-4 · Cited by 34
Metadata
- Authors
- Xie, Z., Enkhjargal, B., Wu, L., Zhou, K., Sun, C., Hu, X., Gospodarev, V., Tang, J., You, C., & Zhang, J. H.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 128
- Pages
- 142-151
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2762753133
- Cited by
- 96
- References
- 7
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. https://app.cochat.ai/papers/10.1016/j.neuropharm.2017.09.040
- The paper
- Xie, Z., Enkhjargal, B., Wu, L., Zhou, K., Sun, C., Hu, X., Gospodarev, V., Tang, J., You, C., & Zhang, J. H. (2018). Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2017.09.040
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.